Floatz logo

Allocetra-Ots

Peritoneal Metastases

Enlivex Therapeutics RDO Ltd.Phase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

32 Active assets in the Peritoneal Metastases cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Ciusss de L'Est de l'Île de Montréal
Phase 3BB
Eloxatin
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 3BB
MITOMYCIN C
H. Lee Moffitt Cancer Center and Research Institute
Phase 4BB
Irinotecan
Catharina Ziekenhuis Eindhoven
Phase 3BB
Irinotecan
Catharina Ziekenhuis Eindhoven
Phase 3BB

View all 42 →

Same molecule, other indications

Allocetra-Ots is also rated in:

acute cholecystitisDormant
CCC
Indicative ·
55 / 100
View asset →
infectious disease with sepsisDormant
CCC
Indicative ·
55 / 100
View asset →
pneumoniaDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →